Rt Hon JACINDA ARDERN: I would actually refute the premise of that question. We have, in our Omicron response plan, embedded rapid antigen testing from phase 2. At the time that we did that, we had millions available. The access or the number of rapid antigen tests has not been an issue, unlike in the likes of Australia, where, at a critical point, they did run out. We've had 10 million arrive recently, another four—there is wide availability. But the question we've asked—